Edition:
United Kingdom

MediciNova Inc (MNOV.OQ)

MNOV.OQ on NASDAQ Stock Exchange Global Market

8.86USD
14 Dec 2018
Change (% chg)

$-0.29 (-3.17%)
Prev Close
$9.15
Open
$9.08
Day's High
$9.29
Day's Low
$8.84
Volume
70,344
Avg. Vol
24,771
52-wk High
$14.50
52-wk Low
$6.30

Chart for

About

Medicinova, Inc. is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029... (more)

Overall

Beta: 0.25
Market Cap(Mil.): ¥24,203.37
Shares Outstanding(Mil.): 35.35
Dividend: --
Yield (%): --

Financials

  MNOV.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -32.95 -- --
ROI: -25.85 9.01 14.96
ROE: -28.52 10.15 16.52

Earnings vs. Estimates